Press release
Biotherapeutics Cell Line Development Market Size to Surge at the CAGR of ~7% throughout the Foreseeable Period
Biotherapeutics Cell Line Development Market: Introduction
According to the report, the global biotherapeutics cell line development market was valued at ~US$ 100 Mn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period. Stable cell lines are widely used in various applications, including biologics production, drug screening, and gene functional studies. These cell lines developments have been gaining significance of late, as many blockbuster drugs include biologics. The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells, with desired plasmids. North America dominated the global biotherapeutics cell line development market in 2019. It is expected to continue its dominance by the end of 2030 in terms of revenue.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8272
Rise in Demand for Biotherapeutics to Drive Biotherapeutics Cell Line Development Market
Blockbuster drugs that have been launched recently primarily contain biopharmaceutical ingredients. The biotherapeutics cell line development market has been expanding, owing to the rise in the demand for these biotherapeutics and biosimilar drugs. For instance, the U.S. FDA approved 12 biologics and 34 small molecules drugs in 2017, while the number increased to 17 biologics and 42 small-molecules new drug approvals in 2018. Increase in geriatric population and prevalence of diseases are key factors driving the global biotherapeutics cell line development market. Government initiatives to boost biotechnology & pharmaceutical sectors and development of advanced technologies to cater to the rising demand for monoclonal antibodies are some of the major factors boosting the global biotherapeutics cell line development market.
Request COVID Analysis on Biotherapeutics Cell Line Development Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8272
Single Cell Cloning to Dominate Biotherapeutics Cell Line Development Market
Based on process, the global biotherapeutics cell line development market has been bifurcated into transfection & selection and single cell cloning. The single cell cloning segment is expected to dominate the global biotherapeutics cell line development market during the forecast period, owing to rise in demand for biotherapeutics, increase in adoption of instruments such as FACS & ClonePix, and higher throughput nature of this method. The single cell cloning segment has been further sub-segmented into manual LDC, FACs, ClonePix, and others.
Outsource CLD Option to Offer Lucrative Opportunities
In terms of CLD option, the global biotherapeutics cell line development market has been divided into in-house, outsource, Do-It-Yourself, and hybrid. The outsource segment accounted for a major share of the market in 2019 and is expected to be a highly promising segment during the forecast period. The increase in demand for outsourced products; cost saving; and rapid delivery of products are some of the major factors driving the outsource segment.
Request Customization on Biotherapeutics Cell Line Development Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=8272
North America to Dominate Biotherapeutics Cell Line Development Market
Based on region, the global biotherapeutics cell line development market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant share of the global biotherapeutics cell line development market in 2019, owing to high funding in new biologic drugs, rise in geriatric population, increase in prevalence of various diseases in developed countries in the region, and growth in government funding for research and development activities. According to the Association of the British Pharmaceutical Industry, around US$ 52 Bn was invested in R&D in the pharmaceutical industry in the U.S. in 2016.
The biotherapeutics cell line development market in Asia Pacific is estimated to expand at a faster CAGR than that in other regions, owing to considerable expansion of the biopharmaceutical industry and significant investment by global players to build manufacturing plants in the region.
Buy Biotherapeutics Cell Line Development Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=8272<ype=S
Competition Landscape
The global biotherapeutics cell line development market is fragmented, with a large number of players operating in the market. Key players operating in the global biotherapeutics cell line development market include Merck KGaA, Becton, Dickinson and Company (BD), Danaher Corporation, Boehringer Ingelheim Group, Thermo Fisher Scientific, Inc., Lonza Group Ltd., Probiogen AG, Solentim Ltd., Selexis SA, and Sysmex Corporation. Mergers, acquisitions, strategic collaborations, and new product & technology launches are some of the major strategies adopted by prominent companies operating in the global biotherapeutics cell line development market.
Global Biotherapeutics Cell Line Development Market: Segmentation
• Biotherapeutics Cell Line Development Market, by Process
o Transfection & Selection
o Single Cell Cloning
o Manual LDC
o FACs
o ClonePix
o Others
• Biotherapeutics Cell Line Development Market, by CLD Option
o In-house
o Outsource
o Do-It-Yourself
o Hybrid
• Biotherapeutics Cell Line Development Market, by Region
o North America
o U.S.
o Canada
o Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
o Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o Rest of Asia Pacific
o Latin America
o Brazil
o Mexico
o Rest of Latin America
o Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
Trending Reports of Transparency Market Research –
Osteoporosis Drugs Market –
https://www.prnewswire.com/news-releases/projected-rise-of-prevalence-of-osteoporosis-in-numerous-regions-drive-demand-for-new-treatment-options-for-osteoporosis-drugs-market-tmr-301271544.html
Vascular Grafts Market –
https://www.prnewswire.com/news-releases/new-engineering-approaches-in-vascular-grafts-market-expands-horizon-of-endovascular-surgeries-synthetic-products-attract-rd-tmr-301278115.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
According to the report, the global biotherapeutics cell line development market was valued at ~US$ 100 Mn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period. Stable cell lines are widely used in various applications, including biologics production, drug screening, and gene functional studies. These cell lines developments have been gaining significance of late, as many blockbuster drugs include biologics. The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells, with desired plasmids. North America dominated the global biotherapeutics cell line development market in 2019. It is expected to continue its dominance by the end of 2030 in terms of revenue.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8272
Rise in Demand for Biotherapeutics to Drive Biotherapeutics Cell Line Development Market
Blockbuster drugs that have been launched recently primarily contain biopharmaceutical ingredients. The biotherapeutics cell line development market has been expanding, owing to the rise in the demand for these biotherapeutics and biosimilar drugs. For instance, the U.S. FDA approved 12 biologics and 34 small molecules drugs in 2017, while the number increased to 17 biologics and 42 small-molecules new drug approvals in 2018. Increase in geriatric population and prevalence of diseases are key factors driving the global biotherapeutics cell line development market. Government initiatives to boost biotechnology & pharmaceutical sectors and development of advanced technologies to cater to the rising demand for monoclonal antibodies are some of the major factors boosting the global biotherapeutics cell line development market.
Request COVID Analysis on Biotherapeutics Cell Line Development Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8272
Single Cell Cloning to Dominate Biotherapeutics Cell Line Development Market
Based on process, the global biotherapeutics cell line development market has been bifurcated into transfection & selection and single cell cloning. The single cell cloning segment is expected to dominate the global biotherapeutics cell line development market during the forecast period, owing to rise in demand for biotherapeutics, increase in adoption of instruments such as FACS & ClonePix, and higher throughput nature of this method. The single cell cloning segment has been further sub-segmented into manual LDC, FACs, ClonePix, and others.
Outsource CLD Option to Offer Lucrative Opportunities
In terms of CLD option, the global biotherapeutics cell line development market has been divided into in-house, outsource, Do-It-Yourself, and hybrid. The outsource segment accounted for a major share of the market in 2019 and is expected to be a highly promising segment during the forecast period. The increase in demand for outsourced products; cost saving; and rapid delivery of products are some of the major factors driving the outsource segment.
Request Customization on Biotherapeutics Cell Line Development Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=8272
North America to Dominate Biotherapeutics Cell Line Development Market
Based on region, the global biotherapeutics cell line development market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant share of the global biotherapeutics cell line development market in 2019, owing to high funding in new biologic drugs, rise in geriatric population, increase in prevalence of various diseases in developed countries in the region, and growth in government funding for research and development activities. According to the Association of the British Pharmaceutical Industry, around US$ 52 Bn was invested in R&D in the pharmaceutical industry in the U.S. in 2016.
The biotherapeutics cell line development market in Asia Pacific is estimated to expand at a faster CAGR than that in other regions, owing to considerable expansion of the biopharmaceutical industry and significant investment by global players to build manufacturing plants in the region.
Buy Biotherapeutics Cell Line Development Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=8272<ype=S
Competition Landscape
The global biotherapeutics cell line development market is fragmented, with a large number of players operating in the market. Key players operating in the global biotherapeutics cell line development market include Merck KGaA, Becton, Dickinson and Company (BD), Danaher Corporation, Boehringer Ingelheim Group, Thermo Fisher Scientific, Inc., Lonza Group Ltd., Probiogen AG, Solentim Ltd., Selexis SA, and Sysmex Corporation. Mergers, acquisitions, strategic collaborations, and new product & technology launches are some of the major strategies adopted by prominent companies operating in the global biotherapeutics cell line development market.
Global Biotherapeutics Cell Line Development Market: Segmentation
• Biotherapeutics Cell Line Development Market, by Process
o Transfection & Selection
o Single Cell Cloning
o Manual LDC
o FACs
o ClonePix
o Others
• Biotherapeutics Cell Line Development Market, by CLD Option
o In-house
o Outsource
o Do-It-Yourself
o Hybrid
• Biotherapeutics Cell Line Development Market, by Region
o North America
o U.S.
o Canada
o Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
o Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o Rest of Asia Pacific
o Latin America
o Brazil
o Mexico
o Rest of Latin America
o Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
Trending Reports of Transparency Market Research –
Osteoporosis Drugs Market –
https://www.prnewswire.com/news-releases/projected-rise-of-prevalence-of-osteoporosis-in-numerous-regions-drive-demand-for-new-treatment-options-for-osteoporosis-drugs-market-tmr-301271544.html
Vascular Grafts Market –
https://www.prnewswire.com/news-releases/new-engineering-approaches-in-vascular-grafts-market-expands-horizon-of-endovascular-surgeries-synthetic-products-attract-rd-tmr-301278115.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend

/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...

/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...

/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...

/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...

/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...

/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...